In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as "Dr.
LONDON, England—A small, long-running randomized trial suggests that transcatheter edge-to-edge repair (TEER) with the MitraClip (Abbott) can achieve similar outcomes to surgery in patients who have ...
Abbott Laboratories, Inc. ABT recently presented late-breaking data from the Landmark COAPT trial for MitraClip, demonstrating the long-term benefits of the device in patients fighting heart failure.
On February 15, FDA announced that Abbott Vascular has received nine reports of its MitraClip delivery system failing to detach from the Clip, which resulted in the death of one patient and open-heart ...
Life became increasingly difficult for those patients who were facing chronic heart problems. Mitral valve leakage or regurgitation is the most common valvular heart disease. With a global prevalence ...
A novel treatment for heart valve disease helped an El Campo couple celebrate their 70th anniversary
When Murray Norman started having trouble breathing in the fall of 2020, he and his wife, Joyce, never expected it to be serious enough that he might need surgery for a leaky heart valve. The problem ...
The US Food and Drug Administration is alerting healthcare providers about the potential for clip lock malfunctions with Abbott's MitraClip's delivery system. "These events appear to occur in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback